Biogas Plants - Global Strategic Business Report
- Language: English
- 212 Pages
- Published: April 2012
- Region: World
Europe Drug Delivery Devices Market Outlook to 2017
Summary
GlobalData’s new report, “Europe Drug Delivery Devices Market Outlook to 2017” provides key market data on the Europe Drug Delivery Devices market – France, Germany, Italy, Spain and United Kingdom. The report provides value (USD million) data for all the market categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Countries covered include France, Germany, Italy, Spain and United Kingdom.
- Market size and company share data for Drug Delivery Devices market categories – Central Venous Catheters, Infusion Systems,Metered Dose Inhaler Devices and Needle Free Injections.
- Annualized market
READ MORE >
1
1
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What is This Report About?
3 Drug Delivery Devices in Europe
3.1 Drug Delivery Devices Cross Country Comparison, Revenue ($m), 2003-2017
3.2 Drug Delivery Devices, Europe, Overall Revenue ($m), 2003-2017
3.3 Drug Delivery Devices, Europe, Category Volume (Units), 2003-2017
3.4 Drug Delivery Devices, Europe, Company share (2009-2010)
4 Drug Delivery Devices In Germany
4.1 Drug Delivery Devices, Germany, Overall Revenue ($m), 2003-2017
4.2 Drug Delivery Devices, Germany, Category Volume (Units), 2003-2017
4.3 Drug Delivery Devices, Germany, Distribution Share (2009-2010)
4.3.1 Central Venous Catheters, Germany, Distribution Share (2009-2010)
4.3.2 Infusion Systems, Germany, Distribution Share (2009-2010)
4.3.3 Metered Dose Inhaler Devices, Germany, Distribution Share (2009-2010)
4.3.4 Needle Free Injections, Germany, Distribution Share (2009-2010)
4.4 Drug Delivery Devices, Germany, Company Share (2009-2010)
4.4.1 Drug Delivery Devices, Germany, Company Share (2009-2010)
4.4.2 Central Venous Catheters, Germany, Company Share (2009-2010)
4.4.3 Infusion Systems, Germany, Company Share (2009-2010)
4.4.4 Metered Dose Inhaler Devices, Germany, Company Share (2009-2010)
4.4.5 Needle Free Injections, Germany, Company Share (2009-2010)
5 Drug Delivery Devices In France
5.1 Drug Delivery Devices, France, Overall Revenue ($m), 2003-2017
5.2 Drug Delivery Devices, France, Category Volume (Units), 2003-2017
5.3 Drug Delivery Devices, France, Distribution Share (2009-2010)
5.3.1 Central Venous Catheters, France, Distribution Share (2009-2010)
5.3.2 Infusion Systems, France, Distribution Share (2009-2010)
5.3.3 Metered Dose Inhaler Devices, France, Distribution Share (2009-2010)
5.3.4 Needle Free Injections, France, Distribution Share (2009-2010)
5.4 Drug Delivery Devices, France, Company Share (2009-2010)
5.4.1 Drug Delivery Devices, France, Company Share (2009-2010)
5.4.2 Central Venous Catheters, France, Company Share (2009-2010)
5.4.3 Infusion Systems, France, Company Share (2009-2010)
5.4.4 Metered Dose Inhaler Devices, France, Company Share (2009-2010)
5.4.5 Needle Free Injections, France, Company Share (2009-2010)
6 Drug Delivery Devices In United Kingdom
6.1 Drug Delivery Devices, United Kingdom, Overall Revenue ($m), 2003-2017
6.2 Drug Delivery Devices, United Kingdom, Category Volume (Units), 2003-2017
6.3 Drug Delivery Devices, United Kingdom, Distribution Share (2009-2010)
6.3.1 Central Venous Catheters, United Kingdom, Distribution Share (2009-2010)
6.3.2 Infusion Systems, United Kingdom, Distribution Share (2009-2010)
6.3.3 Metered Dose Inhaler Devices, United Kingdom, Distribution Share (2009-2010)
6.3.4 Needle Free Injections, United Kingdom, Distribution Share (2009-2010)
6.4 Drug Delivery Devices, United Kingdom, Company Share (2009-2010)
6.4.1 Drug Delivery Devices, United Kingdom, Company Share (2009-2010)
6.4.2 Central Venous Catheters, United Kingdom, Company Share (2009-2010)
6.4.3 Infusion Systems, United Kingdom, Company Share (2009-2010)
6.4.4 Metered Dose Inhaler Devices, United Kingdom, Company Share (2009-2010)
6.4.5 Needle Free Injections, United Kingdom, Company Share (2009-2010)
7 Drug Delivery Devices In Italy
7.1 Drug Delivery Devices, Italy, Overall Revenue ($m), 2003-2017
7.2 Drug Delivery Devices, Italy, Category Volume (Units), 2003-2017
7.3 Drug Delivery Devices, Italy, Distribution Share (2009-2010)
7.3.1 Central Venous Catheters, Italy, Distribution Share (2009-2010)
7.3.2 Infusion Systems, Italy, Distribution Share (2009-2010)
7.3.3 Metered Dose Inhaler Devices, Italy, Distribution Share (2009-2010)
7.3.4 Needle Free Injections, Italy, Distribution Share (2009-2010)
7.4 Drug Delivery Devices, Italy, Company Share (2009-2010)
7.4.1 Drug Delivery Devices, Italy, Company Share (2009-2010)
7.4.2 Central Venous Catheters, Italy, Company Share (2009-2010)
7.4.3 Infusion Systems, Italy, Company Share (2009-2010)
7.4.4 Metered Dose Inhaler Devices, Italy, Company Share (2009-2010)
7.4.5 Needle Free Injections, Italy, Company Share (2009-2010)
8 Drug Delivery Devices In Spain
8.1 Drug Delivery Devices, Spain, Overall Revenue ($m), 2003-2017
8.2 Drug Delivery Devices, Spain, Category Volume (Units), 2003-2017
8.3 Hospital Supplies, Spain, Distribution Share (2009-2010)
8.3.1 Central Venous Catheters, Spain, Distribution Share (2009-2010)
8.3.2 Infusion Systems, Spain, Distribution Share (2009-2010)
8.3.3 Metered Dose Inhaler Devices, Spain, Distribution Share (2009-2010)
8.3.4 Needle Free Injections, Spain, Distribution Share (2009-2010)
8.4 Drug Delivery Devices, Spain, Company Share (2009-2010)
8.4.1 Drug Delivery Devices, Spain, Company Share (2009-2010)
8.4.2 Central Venous Catheters, Spain, Company Share (2009-2010)
8.4.3 Infusion Systems, Spain, Company Share (2009-2010)
8.4.4 Metered Dose Inhaler Devices, Spain, Company Share (2009-2010)
8.4.5 Needle Free Injections, Spain, Company Share (2009-2010)
9 Overview of Key Companies in Europe Drug Delivery Devices Market
9.1 GlaxoSmithKline plc
9.1.1 Company Overview
9.1.2 Share in the Europe Drug Delivery Devices Market
9.2 Boehringer Ingelheim GmbH
9.2.1 Company Overview
9.2.2 Share in the Europe Drug Delivery Devices Market
9.3 AstraZeneca PLC
9.3.1 Company Overview
9.3.2 Share in the Europe Drug Delivery Devices Market
9.4 Sunovion
9.4.1 Share in the Europe Drug Delivery Devices Market
9.5 Baxter International Inc.
9.5.1 Company Overview
9.5.2 Share in the Europe Drug Delivery Devices Market
9.6 B. Braun Melsungen AG
9.6.1 Company Overview
9.6.2 Share in the Europe Drug Delivery Devices Market
9.7 CareFusion Corporation
9.7.1 Company Overview
9.8 Fresenius Kabi AG
9.8.1 Company Overview
9.9 Hospira, Inc.
9.9.1 Company Overview
9.10 Medtronic, Inc.
9.10.1 Company Overview
9.11 Smiths Medical
9.11.1 Company Overview
9.12 Terumo Corporation
9.12.1 Company Overview
9.13 Consort Medical plc
9.13.1 Company Overview
9.14 3M Health Care
9.14.1 Company Overview
9.15 Codman & Shurtleff, Inc.
9.15.1 Company Overview
9.16 JMS CO., LTD.
9.16.1 Company Overview
9.17 Teleflex Incorporated
9.17.1 Company Overview
9.18 Edwards Lifesciences Corporation
9.18.1 Company Overview
9.19 Cook Medical Incorporated
9.19.1 Company Overview
9.20 INJEX - Equidyne Systems
9.20.1 Company Overview
9.21 Bioject Medical Technologies Inc.
9.21.1 Company Overview
9.22 Antares Pharma, Inc.
9.22.1 Company Overview
10 Drug Delivery Devices Market Pipeline Products
11 Financial Deals Landscape
11.1 Acquisition
11.1.1 Runfold Medical Acquires Zimed
11.2 Partnerships
11.2.1 AorTech International Enters Into Technology License Agreement
12 Recent Developments
12.1 Strategy and Business Planning
12.1.1 Aug 19, 2010: Archimedes Pharma Announces New US Headquarters In Bedminster, New Jersey
12.1.2 Jul 27, 2010: GE Healthcare Opens New $15 Million Life Sciences Manufacturing Center In Wales, UK
12.1.3 Jul 13, 2010: GE Healthcare Opens New Medical Technology Manufacturing Facility In Cardiff, UK
12.2 Legal and Regulatory
12.2.1 Jan 17, 2011: GlaxoSmithKline Announces Q4 2010 Legal Charge
13 Appendix
13.1 Definitions of Markets Covered in the Report
13.1.1 Drug Delivery Devices
13.2 Research Methodology
13.3 Secondary Research
13.4 Primary Research
13.5 Models
13.6 Forecasts
13.7 Expert Panels
13.8 Consulting
13.9 Currency Conversion
13.10 Contact Us
13.11 Disclaimer
1.1 List of Tables
Table 1: Drug Delivery Devices, Cross Country Comparison, Revenue ($m), 2003-2017
Table 2: Drug Delivery Devices, Europe, Overall Revenue ($m), 2003-2017
Table 3: Drug Delivery Devices, Europe, Cross-Category Analysis, 2003-2017
Table 4: Drug Delivery Devices, Europe, Overall Revenue ($m), Historic, 2003-2010
Table 5: Drug Delivery Devices, Europe, Overall Revenue ($m), Forecast, 2010-2017
Table 6: Drug Delivery Devices, Europe, Category Volume (Units), 2003-2017
Table 7: Drug Delivery Devices, Europe, Category Volume (Units), Historic, 2003-2010
Table 8: Drug Delivery Devices, Europe, Category Volume (Units), Forecast, 2010-2017
Table 9: Drug Delivery Devices, Europe, Company share by Revenue ($m), 2009-2010
Table 10: Drug Delivery Devices, Germany, Overall Revenue ($m), 2003-2017
Table 11: Drug Delivery Devices, Germany, Overall Revenue ($m), Historic, 2003-2010
Table 12: Drug Delivery Devices, Germany, Overall Revenue ($m), Forecast, 2010-2017
Table 13: Drug Delivery Devices, Germany, Category Volume (Units), 2003-2017
Table 14: Drug Delivery Devices, Germany, Category Volume (Units), Historic, 2003-2010
Table 15: Drug Delivery Devices, Germany, Category Volume (Units), Forecast, 2010-2017
Table 16: Central Venous Catheters, Germany, Distribution Share by Revenue ($m), 2009-2010
Table 17: Infusion Systems, Germany, Distribution Share by Revenue ($m), 2009-2010
Table 18: Metered Dose Inhaler Devices, Germany, Distribution Share by Revenue ($m), 2009-2010
Table 19: Needle Free Injections, Germany, Distribution Share by Revenue ($m), 2009-2010
Table 20: Drug Delivery Devices, Germany, Company Share by Revenue ($m), 2009-2010
Table 21: Central Venous Catheters, Germany, Company Share by Revenue ($m), 2009-2010
Table 22: Infusion Systems, Germany, Company Share by Revenue ($m), 2009-2010
Table 23: Metered Dose Inhaler Devices, Germany, Company Share by Revenue ($m), 2009-2010
Table 24: Needle Free Injections, Germany, Company Share by Revenue ($m), 2009-2010
Table 25: Drug Delivery Devices, France, Overall Revenue ($m), 2003-2017
Table 26: Drug Delivery Devices, France, Overall Revenue ($m), Historic, 2003-2010
Table 27: Drug Delivery Devices, France, Overall Revenue ($m), Forecast, 2010-2017
Table 28: Drug Delivery Devices, France, Category Volume (Units), 2003-2017
Table 29: Drug Delivery Devices, France, Category Volume (Units), Historic, 2003-2010
Table 30: Drug Delivery Devices, France, Category Volume (Units), Forecast, 2010-2017
Table 31: Central Venous Catheters, France, Distribution Share by Revenue ($m), 2009-2010
Table 32: Infusion Systems, France, Distribution Share by Revenue ($m), 2009-2010
Table 33: Metered Dose Inhaler Devices, France, Distribution Share by Revenue ($m), 2009-2010
Table 34: Needle Free Injections, France, Distribution Share by Revenue ($m), 2009-2010
Table 35: Drug Delivery Devices, France, Company Share by Revenue ($m), 2009-2010
Table 36: Central Venous Catheters, France, Company Share by Revenue ($m), 2009-2010
Table 37: Infusion Systems, France, Company Share by Revenue ($m), 2009-2010
Table 38: Metered Dose Inhaler Devices, France, Company Share by Revenue ($m), 2009-2010
Table 39: Needle Free Injections, France, Company Share by Revenue ($m), 2009-2010
Table 40: Drug Delivery Devices, United Kingdom, Overall Revenue ($m), 2003-2017
Table 41: Drug Delivery Devices, United Kingdom, Overall Revenue ($m), Historic, 2003-2010
Table 42: Drug Delivery Devices, United Kingdom, Overall Revenue ($m), Forecast, 2010-2017
Table 43: Drug Delivery Devices, United Kingdom, Category Volume (Units), 2003-2017
Table 44: Drug Delivery Devices, United Kingdom, Category Volume (Units), Historic, 2003-2010
Table 45: Drug Delivery Devices, United Kingdom, Category Volume (Units), Forecast, 2010-2017
Table 46: Central Venous Catheters, United Kingdom, Distribution Share by Revenue ($m), 2009-2010
Table 47: Infusion Systems, United Kingdom, Distribution Share by Revenue ($m), 2009-2010
Table 48: Metered Dose Inhaler Devices, United Kingdom, Distribution Share by Revenue ($m), 2009-2010
Table 49: Needle Free Injections, United Kingdom, Distribution Share by Revenue ($m), 2009-2010
Table 50: Drug Delivery Devices, United Kingdom, Company Share by Revenue ($m), 2009-2010
Table 51: Central Venous Catheters, United Kingdom, Company Share by Revenue ($m), 2009-2010
Table 52: Infusion Systems, United Kingdom, Company Share by Revenue ($m), 2009-2010
Table 53: Metered Dose Inhaler Devices, United Kingdom, Company Share by Revenue ($m), 2009-2010
Table 54: Needle Free Injections, United Kingdom, Company Share by Revenue ($m), 2009-2010
Table 55: Drug Delivery Devices, Italy, Overall Revenue ($m), 2003-2017
Table 56: Drug Delivery Devices, Italy, Overall Revenue ($m), Historic, 2003-2010
Table 57: Drug Delivery Devices, Italy, Overall Revenue ($m), Forecast, 2010-2017
Table 58: Drug Delivery Devices, Italy, Category Volume (Units), 2003-2017
Table 59: Drug Delivery Devices, Italy, Category Volume (Units), Historic, 2003-2010
Table 60: Drug Delivery Devices, Italy, Category Volume (Units), Forecast, 2010-2017
Table 61: Central Venous Catheters, Italy, Distribution Share by Revenue ($m), 2009-2010
Table 62: Infusion Systems, Italy, Distribution Share by Revenue ($m), 2009-2010
Table 63: Metered Dose Inhaler Devices, Italy, Distribution Share by Revenue ($m), 2009-2010
Table 64: Needle Free Injections, Italy, Distribution Share by Revenue ($m), 2009-2010
Table 65: Drug Delivery Devices, Italy, Company Share by Revenue ($m), 2009-2010
Table 66: Central Venous Catheters, Italy, Company Share by Revenue ($m), 2009-2010
Table 67: Infusion Systems, Italy, Company Share by Revenue ($m), 2009-2010
Table 68: Metered Dose Inhaler Devices, Italy, Company Share by Revenue ($m), 2009-2010
Table 69: Needle Free Injections, Italy, Company Share by Revenue ($m), 2009-2010
Table 70: Drug Delivery Devices, Spain, Overall Revenue ($m), 2003-2017
Table 71: Drug Delivery Devices, Spain, Overall Revenue ($m), Historic, 2003-2010
Table 72: Drug Delivery Devices, Spain, Overall Revenue ($m), Forecast, 2010-2017
Table 73: Drug Delivery Devices, Spain, Category Volume (Units), 2003-2017
Table 74: Drug Delivery Devices, Spain, Category Volume (Units), Historic, 2003-2010
Table 75: Drug Delivery Devices, Spain, Category Volume (Units), Forecast, 2010-2017
Table 76: Central Venous Catheters, Spain, Distribution Share by Revenue ($m), 2009-2010
Table 77: Infusion Systems, Spain, Distribution Share by Revenue ($m), 2009-2010
Table 78: Metered Dose Inhaler Devices, Spain, Distribution Share by Revenue ($m), 2009-2010
Table 79: Needle Free Injections, Spain, Distribution Share by Revenue ($m), 2009-2010
Table 80: Drug Delivery Devices, Spain, Company Share by Revenue ($m), 2009-2010
Table 81: Central Venous Catheters, Spain, Company Share by Revenue ($m), 2009-2010
Table 82: Infusion Systems, Spain, Company Share by Revenue ($m), 2009-2010
Table 83: Metered Dose Inhaler Devices, Spain, Company Share by Revenue ($m), 2009-2010
Table 84: Needle Free Injections, Spain, Company Share by Revenue ($m), 2009-2010
Table 85: Drug Delivery Devices Market Pipeline Products
Table 86: Runfold Medical Acquires Zimed
Table 87: AorTech International Enters Into Technology License Agreement
Table 88: USD to Local Currency, Europe, Average Exchange Rate 2003-2010
1.2 List of Figures
Figure 1: Drug Delivery Devices, Cross Country Comparison, Revenue ($m), 2003-2017
Figure 2: Drug Delivery Devices, Europe, Overall Revenue ($m), 2003-2017
Figure 3: Drug Delivery Devices, Europe, Cross-Category Analysis, 2003-2017
Figure 4: Drug Delivery Devices, Europe, Overall Revenue ($m), Historic, 2003-2010
Figure 5: Drug Delivery Devices, Europe, Overall Revenue ($m), Forecast, 2010-2017
Figure 6: Drug Delivery Devices, Europe, Category Volume (Units), 2003-2017
Figure 7: Drug Delivery Devices, Europe, Category Volume (Units), Historic, 2003-2010
Figure 8: Drug Delivery Devices, Europe, Category Volume (Units), Forecast, 2010-2017
Figure 9: Drug Delivery Devices, Europe, Company share (%), 2010
Figure 10: Drug Delivery Devices, Germany, Overall Revenue ($m), 2003-2017
Figure 11: Drug Delivery Devices, Germany, Overall Revenue ($m), Historic, 2003-2010
Figure 12: Drug Delivery Devices, Germany, Overall Revenue ($m), Forecast, 2010-2017
Figure 13: Drug Delivery Devices, Germany, Category Volume (Units), 2003-2017
Figure 14: Drug Delivery Devices, Germany, Category Volume (Units), Historic, 2003-2010
Figure 15: Drug Delivery Devices, Germany, Category Volume (Units), Forecast, 2010-2017
Figure 16: Drug Delivery Devices, Germany, Company Share (%), 2010
Figure 17: Central Venous Catheters, Germany, Company Share (%), 2010
Figure 18: Infusion Systems, Germany, Company Share (%), 2010
Figure 19: Metered Dose Inhaler Devices, Germany, Company Share (%), 2010
Figure 20: Needle Free Injections, Germany, Company Share (%), 2010
Figure 21: Drug Delivery Devices, France, Overall Revenue ($m), 2003-2017
Figure 22: Drug Delivery Devices, France, Overall Revenue ($m), Historic, 2003-2010
Figure 23: Drug Delivery Devices, France, Overall Revenue ($m), Forecast, 2010-2017
Figure 24: Drug Delivery Devices, France, Category Volume (Units), 2003-2017
Figure 25: Drug Delivery Devices, France, Category Volume (Units), Historic, 2003-2010
Figure 26: Drug Delivery Devices, France, Category Volume (Units), Forecast, 2010-2017
Figure 27: Drug Delivery Devices, France, Company Share (%), 2010
Figure 28: Central Venous Catheters, France, Company Share (%), 2010
Figure 29: Infusion Systems, France, Company Share (%), 2010
Figure 30: Metered Dose Inhaler Devices, France, Company Share (%), 2010
Figure 31: Needle Free Injections, France, Company Share (%), 2010
Figure 32: Drug Delivery Devices, United Kingdom, Overall Revenue ($m), 2003-2017
Figure 33: Drug Delivery Devices, United Kingdom, Overall Revenue ($m), Historic, 2003-2010
Figure 34: Drug Delivery Devices, United Kingdom, Overall Revenue ($m), Forecast, 2010-2017
Figure 35: Drug Delivery Devices, United Kingdom, Category Volume (Units), 2003-2017
Figure 36: Drug Delivery Devices, United Kingdom, Category Volume (Units), Historic, 2003-2010
Figure 37: Drug Delivery Devices, United Kingdom, Category Volume (Units), Forecast, 2010-2017
Figure 38: Drug Delivery Devices, United Kingdom, Company Share (%), 2010
Figure 39: Central Venous Catheters, United Kingdom, Company Share (%), 2010
Figure 40: Infusion Systems, United Kingdom, Company Share (%), 2010
Figure 41: Metered Dose Inhaler Devices, United Kingdom, Company Share (%), 2010
Figure 42: Needle Free Injections, United Kingdom, Company Share (%), 2010
Figure 43: Drug Delivery Devices, Italy, Overall Revenue ($m), 2003-2017
Figure 44: Drug Delivery Devices, Italy, Overall Revenue ($m), Historic, 2003-2010
Figure 45: Drug Delivery Devices, Italy, Overall Revenue ($m), Forecast, 2010-2017
Figure 46: Drug Delivery Devices, Italy, Category Volume (Units), 2003-2017
Figure 47: Drug Delivery Devices, Italy, Category Volume (Units), Historic, 2003-2010
Figure 48: Drug Delivery Devices, Italy, Category Volume (Units), Forecast, 2010-2017
Figure 49: Drug Delivery Devices, Italy, Company Share (%), 2010
Figure 50: Central Venous Catheters, Italy, Company Share (%), 2010
Figure 51: Infusion Systems, Italy, Company Share (%), 2010
Figure 52: Metered Dose Inhaler Devices, Italy, Company Share (%), 2010
Figure 53: Needle Free Injections, Italy, Company Share (%), 2010
Figure 54: Drug Delivery Devices, Spain, Overall Revenue ($m), 2003-2017
Figure 55: Drug Delivery Devices, Spain, Overall Revenue ($m), Historic, 2003-2010
Figure 56: Drug Delivery Devices, Spain, Overall Revenue ($m), Forecast, 2010-2017
Figure 57: Drug Delivery Devices, Spain, Category Volume (Units), 2003-2017
Figure 58: Drug Delivery Devices, Spain, Category Volume (Units), Historic, 2003-2010
Figure 59: Drug Delivery Devices, Spain, Category Volume (Units), Forecast, 2010-2017
Figure 60: Drug Delivery Devices, Spain, Company Share (%), 2010
Figure 61: Central Venous Catheters, Spain, Company Share (%), 2010
Figure 62: Infusion Systems, Spain, Company Share (%), 2010
Figure 63: Metered Dose Inhaler Devices, Spain, Company Share (%), 2010
Figure 64: Needle Free Injections, Spain, Company Share (%), 2010
Figure 65: GlaxoSmithKline plc, Company Share (%),Europe Drug Delivery Devices Market, 2010
Figure 66: Boehringer Ingelheim GmbH, Company Share (%),Europe Drug Delivery Devices Market, 2010
Figure 67: AstraZeneca PLC, Company Share (%),Europe Drug Delivery Devices Market, 2010
Figure 68: Sunovion, Company Share (%),Europe Drug Delivery Devices Market, 2010
Figure 69: Baxter International Inc., Company Share (%),Europe Drug Delivery Devices Market, 2010
Figure 70: B. Braun Melsungen AG, Company Share (%),Europe Drug Delivery Devices Market, 2010
GlaxoSmithKline plc
Boehringer Ingelheim GmbH
AstraZeneca PLC
Sunovion
Baxter International Inc.
B. Braun Melsungen AG
CareFusion Corporation
Fresenius Kabi AG
Hospira, Inc.
Medtronic, Inc.
Smiths Medical
Terumo Corporation
Consort Medical plc
3M Health Care
Codman & Shurtleff, Inc.
JMS CO., LTD.
Teleflex Incorporated
Edwards Lifesciences Corporation
Cook Medical Incorporated
INJEX - Equidyne Systems
Bioject Medical Technologies Inc.
Antares Pharma, Inc.
| Format | Properties | |
|---|---|---|
| Electronic (PDF) | The report will be emailed to you. The report is sent in PDF format. | This is a single user license, allowing one specific user access to the product. |
| Site License | The report will be emailed to you. The report is sent in PDF format. | This is a site license, allowing all users within a given geographical location of your organisation access to the product. |
| Enterprisewide | The report will be emailed to you. The report is sent in PDF format. | This is an enterprise license, allowing all employees within your organisation access to the product. |